![Joachim-Friedrich Kapp](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Joachim-Friedrich Kapp
Directeur/Membre du Conseil chez Sartorius CellGenix GmbH
Profil
Joachim-Friedrich Kapp is currently a Member-Supervisory Board at Sartorius CellGenix GmbH.
Previously, he held positions as a Director at Titan Pharmaceuticals, Inc. from 2005 to 2010, a Director at Bayer Pharma AG, a Director-Clinical Development at Genelux Corp., and the President-Global Business Unit at Bayer Schering Pharma AG.
He obtained a doctorate degree from the University of Duisburg-Essen.
Postes actifs de Joachim-Friedrich Kapp
Sociétés | Poste | Début |
---|---|---|
Sartorius CellGenix GmbH
![]() Sartorius CellGenix GmbH BiotechnologyHealth Technology CellGenix GmbH provides biopharmaceutical products. Its products include CellGro Cytokines, CellGro Supplements and Cells, Bioprocessing Containers and CellGro Serum-free Media. It is supplier of GMP (Good Manufacturing Practice) manufactured cytokines and serum-free media for cell therapy applications. The company was founded in 1994 and is headquartered in Freiburg, Germany. | Directeur/Membre du Conseil | 18/04/2011 |
Anciens postes connus de Joachim-Friedrich Kapp
Sociétés | Poste | Fin |
---|---|---|
TITAN PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 26/10/2010 |
Bayer Pharma AG
![]() Bayer Pharma AG Pharmaceuticals: MajorHealth Technology Bayer Pharma AG engages in the development and production of prescription drugs for the treatment of cardiovascular diseases and women's illnesses, as well as special therapy in the areas of oncology, hematology, and ophthalmology. It also offers medical equipment used in diagnostic imaging with applications in the field of radiology. The company was founded on March 9, 1965 and is headquartered in Berlin, Germany. | Directeur/Membre du Conseil | - |
GENELUX CORPORATION | Directeur Technique/Scientifique/R&D | - |
Bayer Schering Pharma AG | Corporate Officer/Principal | - |
Formation de Joachim-Friedrich Kapp
University of Duisburg-Essen | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
TITAN PHARMACEUTICALS, INC. | Health Technology |
GENELUX CORPORATION | Health Technology |
Entreprise privées | 3 |
---|---|
Bayer Schering Pharma AG | Health Technology |
Bayer Pharma AG
![]() Bayer Pharma AG Pharmaceuticals: MajorHealth Technology Bayer Pharma AG engages in the development and production of prescription drugs for the treatment of cardiovascular diseases and women's illnesses, as well as special therapy in the areas of oncology, hematology, and ophthalmology. It also offers medical equipment used in diagnostic imaging with applications in the field of radiology. The company was founded on March 9, 1965 and is headquartered in Berlin, Germany. | Health Technology |
Sartorius CellGenix GmbH
![]() Sartorius CellGenix GmbH BiotechnologyHealth Technology CellGenix GmbH provides biopharmaceutical products. Its products include CellGro Cytokines, CellGro Supplements and Cells, Bioprocessing Containers and CellGro Serum-free Media. It is supplier of GMP (Good Manufacturing Practice) manufactured cytokines and serum-free media for cell therapy applications. The company was founded in 1994 and is headquartered in Freiburg, Germany. | Health Technology |